Tranexamic Acid as a haemostatic adjunct to ornipressin during open myomectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201203000369163

Enrollment

Registered

2012-03-06

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery myomectomy

Interventions

Tranexamic Acid

Ornipressin

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patient with documented symptomatic uterine fibroids Written informed consent No prior treatment using GnRh analogues or antagonists No History of bleeding disorder prior use of anticoagulants No prior history of DVT or prothrombotic state

Exclusion criteria

Exclusion criteria: Patient without fibroids Patient with Coagulopathies or treatment with anticoagulants Patient who declines to give consent

Design outcomes

Primary

Measure	Time frame
Blood loss in each group	—

Secondary

Measure	Time frame
Duration of surgery;Number of pints transfused;Hospital stay	—

Countries

Kenya

Contacts

Public ContactWilliam Stones

Professor and Chair of Obstetrics and Gynecology

stones.william@aku.edu0734364203

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026